Cargando…
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients
Multiple Sclerosis (MuS) is a complex multifactorial neuropathology, resulting in heterogeneous clinical presentation. A very active MuS research field concerns the discovery of biomarkers helpful to make an early and definite diagnosis. The sphingomyelin pathway has emerged as a molecular mechanism...
Autores principales: | Pieragostino, Damiana, Cicalini, Ilaria, Lanuti, Paola, Ercolino, Eva, di Ioia, Maria, Zucchelli, Mirco, Zappacosta, Romina, Miscia, Sebastiano, Marchisio, Marco, Sacchetta, Paolo, Onofrj, Marco, Del Boccio, Piero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814401/ https://www.ncbi.nlm.nih.gov/pubmed/29449691 http://dx.doi.org/10.1038/s41598-018-21497-5 |
Ejemplares similares
-
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy
por: Rossi, Claudia, et al.
Publicado: (2018) -
Advances in Lipidomics for Cancer Biomarkers Discovery
por: Perrotti, Francesca, et al.
Publicado: (2016) -
Neurodegenerative diseases as proteinopathies-driven immune disorders
por: Ciccocioppo, Fausta, et al.
Publicado: (2019) -
Serum lipidomic study reveals potential early biomarkers for predicting response to chemoradiation therapy in advanced rectal cancer: A pilot study
por: Del Boccio, Piero, et al.
Publicado: (2017) -
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid
por: Cicalini, Ilaria, et al.
Publicado: (2019)